EUVIMEDEUVIMED entdecken
Crossref

Engineered Cyclotide Blocks Neuronal Excitotoxicity

Daryl Ariawan iD, Julia van der Hoven, Nicolle Morey, Kanishka Pushpitha, Sian Genoud iD, Holly Stefen, Sanne Veltman, Magdalena Przybyla, Yuanyuan Deng, Thomas Fath iD, Ole Tietz, Janet van Eersel und 1 weitere

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Daryl Ariawan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Macquarie Medical School, Macquarie University 2109 Sydney, Australia. Hauptthemen laut MEDLINE: Neurons, Receptors, N-Methyl-D-Aspartate, Cyclotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council, Dementia Australia Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclotides are naturally occurring cyclic peptides with three disulfide bonds, offering remarkable stability. In neurological disorders, the formation of a complex between postsynaptic density protein 95 and NMDA receptors (NMDARs) can lead to neuronal cell death. In this study, we modified the MCoTI-II cyclotide backbone with polyarginines for enhanced intracellular delivery and grafted a 9-amino acid PSD-95-NMDAR inhibitor sequence, NR2B9c, into loop 6. We found that incorporating polyarginines into the cyclotide backbone significantly improved uptake into neuronal cells. Primary neurons treated with the NR2B9c cyclotide (c5R-NR2B9c) prevented cell death in response to high concentrations of N-methyl-d-aspartate (NMDA), demonstrating protection from excitotoxicity. Administration of c5R-NR2B9c in a chemically induced seizure model in mice resulted in increased survival and reduced seizure severity. Overall, we show that modifying cyclotides with a polyarginine backbone can enhance the delivery of therapeutic peptides into neuronal cells, which can be utilized to administer therapeutic peptides for the protection of neuronal cells from excitotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuronsReceptors, N-Methyl-D-AspartateCyclotidesAnimalsMiceSeizuresProtein EngineeringN-MethylaspartateMaleHumansMice, Inbred C57BLNeuroprotective AgentsRatsCells, Cultured

Substanzen

Receptors, N-Methyl-D-AspartateCyclotidesN-MethylaspartateNeuroprotective Agents

Autor:innen und Institutionen

  • Dementia Research Centre, Macquarie Medical School, Macquarie University 2109 Sydney, Australia.

ORCID-Profile: Daryl Ariawan, Sian Genoud, Thomas Fath

Förderung

  • National Health and Medical Research Council
  • Australian Research Council
  • Dementia Australia Research Foundation

Zitieren

APA

Ariawan, D., van der Hoven, J., Morey, N., Pushpitha, K., Genoud, S., Stefen, H., Veltman, S., Przybyla, M., Deng, Y., Fath, T., Tietz, O., van Eersel, J., & Ittner, L. M. (2025). Engineered Cyclotide Blocks Neuronal Excitotoxicity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01710

Vancouver

Ariawan D, van der Hoven J, Morey N, Pushpitha K, Genoud S, Stefen H, et al. Engineered Cyclotide Blocks Neuronal Excitotoxicity. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01710

BibTeX
@article{Ariawan2025,
  author = {Ariawan, Daryl and van der Hoven, Julia and Morey, Nicolle and Pushpitha, Kanishka and Genoud, Sian and Stefen, Holly and Veltman, Sanne and Przybyla, Magdalena and Deng, Yuanyuan and Fath, Thomas and Tietz, Ole and van Eersel, Janet and Ittner, Lars Matthias},
  title = {Engineered Cyclotide Blocks Neuronal Excitotoxicity},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01710}
}
Kostenlos starten →